Last week, state officials in Michigan announced that research projects financed by the state’s adult-use marijuana program will assess the effects of medical cannabis in military veterans. The projects have been allocated $20 million, with $13 million of this amount being used to investigate the effectiveness of cannabis in preventing veteran suicide and treating the medical conditions that impact armed service veterans in the United States. This grant, which was awarded to the Multidisciplinary Association for Psychedelic Studies (“MAPS”), will also finance a phase 2 study on the effectiveness of inhaled botanical cannabis in treating post-traumatic stress disorder (“PTSD”). The funds come from the state’s Veteran Cannabis Research Grant Program, which was established in 2018 by a legalization measure approved by voters. For the study, researchers plan to recruit more than 300 veterans who will spend 35 or so days self-administering self-titrated inhaled doses of high-quality botanical marijuana. MAPS asserts that substance-use disorders, depression, and PTSD contributed significantly to suicidality and were common disorders among veterans.

CannabisNewsWire, 08/20/2021 04:20:00

Open article: